Find out more about AIQ Solutions technologies at kiosk IH22!

AIQ Solutions has been awarded a $2,000,000 Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to develop and commercialize novel technology for analysis and prediction of treatment response in patients with metastatic cancer treated with immunotherapy.

Stop by our booth #923

Immuno-Oncology 360 2022 March 16-18, 2022 New York Marriott Brooklyn Bridge

AIQ Solutions will be attending J.P. Morgan 39th Annual Healthcare Conference from January 11th through January 15th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions and our treatment response quantification and prediction technology.

AIQ Solutions will be attending Immuno-Oncology 360° from February 23rd through 26th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

AIQ Solutions will be attending ASCO Genitourinary Cancers Symposium from February 11th through 13th, 2021 in a virtual format. Request a meeting to learn more about AIQ Solutions, and our treatment response quantification and prediction technology.

Flywheel and AIQ Solutions recently announced a partnership to offer a data management and analysis solution to increase clinicians’ and researchers’ understanding of treatment response for complex diseases that include the largest research area of oncology. The combination of Flywheel’s cloud-scale data management and collaboration platform along with the powerful AIQ technology will provide a scalable solution for improved patient management and the overall delivery of accurate data for the therapeutic area.